Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 5153 - 5160 of 12089 results
AB-375 Privacy: Personal Information: Businesses
June 13, 2019| Article| Viewpoint
Heritage Pharmaceuticals Admits to Generic Drug Price Fixing Scheme
June 13, 2019| Blog| Viewpoint
Canon and Toshiba Pay $5 Million for HSR Avoidance Scheme
June 13, 2019| Alert| Viewpoint
The Bubbler - June 2019
June 13, 2019| Blog| Viewpoint
What’s New In Westchester County
June 13, 2019| Blog| Viewpoint
Application to Compel Arbitration Under New York CPLR 7503: What Does It Mean to Be “Aggrieved”?
June 13, 2019| Blog| Viewpoint
Breaking News: Three Month Delay for Massachusetts Paid Family and Medical Leave
June 12, 2019| Blog| Viewpoint
Understanding the USPTO’s Interpretation of 35 U.S.C. § 112 for Computer-Implemented Functional Claim Limitations
June 12, 2019| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|